ProMetic Life Sciences Inc. (PLI) PT Raised to C$3.30This is almost hilarious... ProMetic Life Sciences Inc. (TSE:PLI) had its price objective hoisted by equities researchers at Paradigm Capital from C$2.90 to C$3.30 in a note issued to investors on Monday, StockTargetPrices.com reports. The firm currently has a buy rating on the stock. Paradigm Capitals price objective would indicate a potential upside of 6.11% from the stocks current price. https://www.sfhfm.org/prometic-life-sciences-inc-pli-pt-raised-to-c3-30/